SUPER LEAGUE ENTERPRISE INC (SLE) Fundamental Analysis & Valuation

NASDAQ:SLE • US86804F5098

Current stock price

5.12 USD
+0.67 (+15.06%)
At close:
5.13 USD
+0.01 (+0.2%)
After Hours:

This SLE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SLE Profitability Analysis

1.1 Basic Checks

  • In the past year SLE has reported negative net income.
  • SLE had a negative operating cash flow in the past year.
  • In the past 5 years SLE always reported negative net income.
  • In the past 5 years SLE always reported negative operating cash flow.
SLE Yearly Net Income VS EBIT VS OCF VS FCFSLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • SLE's Return On Assets of -100.63% is on the low side compared to the rest of the industry. SLE is outperformed by 91.30% of its industry peers.
Industry RankSector Rank
ROA -100.63%
ROE N/A
ROIC N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
SLE Yearly ROA, ROE, ROICSLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

  • SLE's Gross Margin of 39.63% is on the low side compared to the rest of the industry. SLE is outperformed by 69.57% of its industry peers.
  • SLE's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SLE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
SLE Yearly Profit, Operating, Gross MarginsSLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SLE Health Analysis

2.1 Basic Checks

  • SLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SLE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SLE has been increased compared to 5 years ago.
  • Compared to 1 year ago, SLE has a worse debt to assets ratio.
SLE Yearly Shares OutstandingSLE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10K 20K 30K
SLE Yearly Total Debt VS Total AssetsSLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • SLE has an Altman-Z score of -48.59. This is a bad value and indicates that SLE is not financially healthy and even has some risk of bankruptcy.
  • SLE's Altman-Z score of -48.59 is on the low side compared to the rest of the industry. SLE is outperformed by 85.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -48.59
ROIC/WACCN/A
WACC7.27%
SLE Yearly LT Debt VS Equity VS FCFSLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.46 indicates that SLE may have some problems paying its short term obligations.
  • SLE has a worse Current ratio (0.46) than 88.41% of its industry peers.
  • A Quick Ratio of 0.46 indicates that SLE may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.46, SLE is not doing good in the industry: 88.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
SLE Yearly Current Assets VS Current LiabilitesSLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SLE Growth Analysis

3.1 Past

  • SLE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.21%, which is quite impressive.
  • The Revenue for SLE has decreased by -48.05% in the past year. This is quite bad
  • Measured over the past years, SLE shows a very strong growth in Revenue. The Revenue has been growing by 71.84% on average per year.
EPS 1Y (TTM)22.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.09%
Revenue 1Y (TTM)-48.05%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-45.32%

3.2 Future

  • SLE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.61% yearly.
  • SLE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.37% yearly.
EPS Next Y52.67%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-35.24%
Revenue Next 2Y-9.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SLE Yearly Revenue VS EstimatesSLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
SLE Yearly EPS VS EstimatesSLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -2K -4K -6K

More info and screens

Find the best growth stocksShow best growing peers

1

4. SLE Valuation Analysis

4.1 Price/Earnings Ratio

  • SLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLE Price Earnings VS Forward Price EarningsSLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLE Per share dataSLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • SLE's earnings are expected to grow with 38.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SLE Dividend Analysis

5.1 Amount

  • SLE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLE Fundamentals: All Metrics, Ratios and Statistics

SUPER LEAGUE ENTERPRISE INC

NASDAQ:SLE (3/17/2026, 8:00:02 PM)

After market: 5.13 +0.01 (+0.2%)

5.12

+0.67 (+15.06%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners10.08%
Inst Owner Change-99.98%
Ins Owners18.99%
Ins Owner Change97.9%
Market Cap5.99M
Revenue(TTM)11.57M
Net Income(TTM)-8.76M
Analysts80
Price Target53.04 (935.94%)
Short Float %7.11%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.58%
Min EPS beat(2)18.52%
Max EPS beat(2)42.63%
EPS beat(4)3
Avg EPS beat(4)3.69%
Min EPS beat(4)-71.36%
Max EPS beat(4)42.63%
EPS beat(8)5
Avg EPS beat(8)-0.79%
EPS beat(12)9
Avg EPS beat(12)10.87%
EPS beat(16)13
Avg EPS beat(16)13.01%
Revenue beat(2)1
Avg Revenue beat(2)-7.53%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)14.28%
Revenue beat(4)1
Avg Revenue beat(4)-14.74%
Min Revenue beat(4)-38.33%
Max Revenue beat(4)14.28%
Revenue beat(8)2
Avg Revenue beat(8)-15.18%
Revenue beat(12)3
Avg Revenue beat(12)-12.5%
Revenue beat(16)5
Avg Revenue beat(16)-8.27%
PT rev (1m)0%
PT rev (3m)345.71%
EPS NQ rev (1m)60.39%
EPS NQ rev (3m)-250.18%
EPS NY rev (1m)58.1%
EPS NY rev (3m)-327.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-21.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-109.84
EYN/A
EPS(NY)-7.88
Fwd EYN/A
FCF(TTM)-8.82
FCFYN/A
OCF(TTM)-8.64
OCFYN/A
SpS9.89
BVpS-1.71
TBVpS-5.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.63%
FCFM N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
F-Score2
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.48%
Cap/Sales 1.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z -48.59
F-Score2
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)20.68%
Cap/Depr(5y)37.55%
Cap/Sales(3y)4.74%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.09%
EPS Next Y52.67%
EPS Next 2Y38.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.05%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-45.32%
Revenue Next Year-35.24%
Revenue Next 2Y-9.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.47%
OCF growth 3YN/A
OCF growth 5YN/A

SUPER LEAGUE ENTERPRISE INC / SLE Fundamental Analysis FAQ

What is the fundamental rating for SLE stock?

ChartMill assigns a fundamental rating of 1 / 10 to SLE.


What is the valuation status for SLE stock?

ChartMill assigns a valuation rating of 1 / 10 to SUPER LEAGUE ENTERPRISE INC (SLE). This can be considered as Overvalued.


What is the profitability of SLE stock?

SUPER LEAGUE ENTERPRISE INC (SLE) has a profitability rating of 0 / 10.


Can you provide the financial health for SLE stock?

The financial health rating of SUPER LEAGUE ENTERPRISE INC (SLE) is 0 / 10.